Christoph Ullmer

6PUBLICATIONS
18CO-AUTHORS
Gene and molecular therapyBiologically active moleculesGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 09, 2026
VEGF-A Antisense Oligonucleotide Therapy Inhibits Corneal Neovascularisation and Enhances Graft Survival in Murine High-Risk Corneal Transplantation.

|Jun 21, 2024
A highly potent, orally bioavailable pyrazole-derived cannabinoid CB2 receptor-selective full agonist for in vivo studies.

Andrea Chicca, Daniel Batora, Christoph Ullmer

|Feb 15, 2022
Elevated Levels of Growth/Differentiation Factor-15 in the Aqueous Humor and Serum of Glaucoma Patients.

Rupalatha Maddala, Leona T Y Ho, Shruthi Karnam

|Jan 22, 2020
Highly Selective, Amine-Derived Cannabinoid Receptor 2 Probes.

Matthias V Westphal, Roman C Sarott, Elisabeth A Zirwes

|Sep 22, 2019
Selective Cannabinoid 2 Receptor Agonists as Potential Therapeutic Drugs for the Treatment of Endotoxin-Induced Uveitis.

Richard Frederick Porter, Anna-Maria Szczesniak, James Thomas Toguri

Pageof 1

Frequent Collaborators

2 joint publications

Uwe Grether

1 joint publications

Richard Frederick Porter

1 joint publications

Brent Johnston

1 joint publications

Christian Lehmann